Eterna Therapeutics Inc Cash Flow Reinvestment Rate
Eterna Therapeutics Inc cash flow reinvestment rate. Eterna Therapeutics Inc (ERNA) has a Cash Flow Reinvestment Rate of 0.00x as of September 2019, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $88.00 Million. Explore Eterna Therapeutics Inc (ERNA) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Eterna Therapeutics Inc (2009–2019)
Cash flow reinvestment rate of Eterna Therapeutics Inc from 2009 to 2019. Historical reinvestment intensity for Eterna Therapeutics Inc across 9 annual periods. Explore Eterna Therapeutics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Eterna Therapeutics Inc Cash Flow Reinvestment Rate by Year (2009–2019)
Eterna Therapeutics Inc cash flow reinvestment rate by year from 2009 to 2019. Year-by-year capital reinvestment analysis for Eterna Therapeutics Inc. For the full cash flow conversion analysis, see ERNA cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.40x | $1.09 Million | $2.74 Million | $1.09 Million | ▼ -66.2% |
| 2018 | 1.18x | $1.61 Million | $1.36 Million | $1.61 Million | ▼ -55.3% |
| 2017 | 2.64x | $1.45 Million | $549.00K | $1.45 Million | ▼ -92.8% |
| 2016 | 36.52x | $840.00K | $23.00K | $840.00K | ▲ +6233.0% |
| 2013 | 0.58x | $861.00K | $1.49 Million | $861.00K | ▲ +1.4% |
| 2012 | 0.57x | $1.23 Million | $2.16 Million | $1.23 Million | ▼ -79.5% |
| 2011 | 2.78x | $1.59 Million | $574.00K | $1.59 Million | ▲ +494.2% |
| 2010 | 0.47x | $1.32 Million | $2.83 Million | $1.32 Million | ▼ -38.8% |
| 2009 | 0.76x | $1.91 Million | $2.50 Million | $1.91 Million | — |